Without such a trial, the appearance of efficacy may be an illusion, because other factors would have led to a lower rate of infection anyway. Yet if a promising vaccine is available – and if safety trials in healthy human volunteers who are not at risk of infection demonstrate that it does no harm – to deny it to those who are tending to the sick and dying, at great risk to their own health, seems unethical.